mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.5 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.5 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.5 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.036 |
0.5 |
mRNA |
skepinone-L |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.5 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.5 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.5 |